Geographically, in Point-of-Care Diagnostics Market North America estimated to command largest share in 2016, followed by Europe. Point-of-care diagnostics market expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a CAGR of 9.8% during forecast period. Rise in prevalence of lifestyle and infectious diseases & increasing inclination towards home healthcare across globe are key factors fueling growth of market across globe.
Complete report on Point-of-Care Diagnostics Market spread across 221 Pages, Profiling 11 Companies and Supported with 94 Tables and 55 Figures is now available at www.reportsnreports.com/reports/27…cast-to-2018.html
In this report, the point-of-care diagnostics market has been segmented on the basis of product (covering glucose monitoring testing kits, cardio metabolic testing kits, infectious disease testing kits, and urinalysis testing kits, among others), mode of prescription (OTC and prescription-based testing kits), end-users (professional diagnostic centers, home care, and research laboratories), and region (North America, Europe, APAC, and RoW).
- Point-of-care diagnostic manufacturing companies
- Clinical laboratories
- Hospitals, clinics, and special areas (such as sports and military)
- Research institutes and clinical research organizations (CROs)
- Market research and consulting firms
All possible parameters that affect markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine percentage shares of each product in emerging nations.
In addition, healthcare decentralization, miniaturization of POC testing devices, increasing number of conferences & events, & POC tests with multiplexing capabilities are offering new growth opportunities for players in point-of-care diagnostics market.Report provides qualitative insights about growth rates and market drivers for all subsegments.
It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment.
Global Market Drivers
1 High Prevalence of Infectious Diseases in Developing Countries
2 Increasing Incidence of Lifestyle Diseases
3 Rising Usage of Home-Based POC Devices
4 Growing Government Support
5 Private Investments and Venture Capital Activities
6 Technological Advancements and New Product Launches
7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
9 Rising Number of Clia-Waived POC Tests
Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc.
(U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players in the market.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the point-of-care diagnostics market in 2016, followed by Europe.
A combination of bottom-up and top-down approaches was used to calculate market sizes and growth rates of market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.